Filter
2548
Filtered Results: 2548
Text search:
drug
trial
Featured
Recommendations
234
New Publications
492
Language
Document type
No document type
1485
Studies & Reports
406
Guidelines
403
Manuals
106
Strategic & Response Plan
54
Fact sheets
41
Training Material
22
Situation Updates
11
Infographics
8
Resource Platforms
6
Brochures
5
App
1
Countries / Regions
India
144
Global
95
South Africa
65
Western and Central Europe
55
Kenya
44
Nigeria
39
Ethiopia
37
Uganda
34
Africa
31
Tanzania
29
Eastern Europe
29
Liberia
29
Zambia
28
Malawi
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
22
Latin America and the Carribbean
22
Zimbabwe
20
Rwanda
19
Asia
18
Bangladesh
18
Philippines
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
Namibia
13
East and Southern Africa
12
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
10
Germany
10
West and Central Africa
10
South Sudan
9
Indonesia
9
USA
8
Middle East and North Africa
8
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Thailand
6
Syria
6
Cameroon
5
Albania
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Senegal
4
Burkina Faso
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Venezuela
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
689
Clinical Guidelines
322
Public Health
130
Women & Child Health
99
Key Resources
36
Pharmacy & Technologies
30
Capacity Building
17
Toolboxes
HIV
345
Mental Health
340
TB
301
COVID-19
162
NTDs
150
AMR
89
NCDs
77
Pharmacy
72
Ebola & Marburg
58
Rapid Response
35
Caregiver
32
Refugee
28
Malaria
27
Disability
24
Planetary Health
23
Health Financing Toolbox
17
Global Health Education
15
Conflict
14
Polio
10
Social Ethics
7
Cholera
6
Specific Hazards
5
Natural Hazards
5
Zika
3
Human Rights, Minimum Standards and Monitoring at the European and International Levels
National HIV curriculum
You can always find the most up to date version of this document at
https://www.hiv.uw.edu/go/co-occurring-conditions/opportunistic-infections-prevention/coreconcept/all
Q 12: In children and adolescents with anxiety disorders, what is the effectiveness and safety, considering system issues in low- and middle-income countries, of using pharmacological interventions in non-specialist settings?
July 2019
Policy brief
HIV Treatment
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)...
Convention for the Protection of Human Rights and Fundamental Freedoms; Latest version from 2010.
For versions in French, Italian, German and Russian check:
http://www.cö.int/en/web/conventions/full-list/-/conventions/treaty/005?_cöconventions_WAR_cöconventionsportlet_languageId=en_GB
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris...
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Accessed December 2017
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
